Skip to main content

Definium Therapeutics, Inc.

DFTX
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
SEC CIK
0001813814

In the last 90 days, Definium Therapeutics, Inc. insiders filed 0 open-market purchases and 6 sales; 362 institutions reported holding it in 13F filings for Q2 2026, worth $5.35B in total; Duquesne Family Office is the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Definium Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of DFTX: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1582174+18
Shares49.5M19.0K41.5M−7.96M (−16.1%)
Value$281.6M$108.2K$288.9M+$7.36M (+2.6%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held Definium Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to DFTX in Q4 2024
InstitutionSharesValue% of portfolio
Tang Capital Management LLC200,000$1.39M0.09%
Susquehanna International Group, LLP198,420$1.38M0.00%
Allostery Investments LP130,000$904.8K1.78%
BIT Capital GmbH63,405$441.3K0.04%
Clough Capital Partners L P33,900$235.9K0.03%
ADAR1 Capital Management, LLC25,000$174.0K0.04%
Raymond James Financial Inc16,004$111.4K0.00%
China Universal Asset Management Co., Ltd.15,549$108.2K0.01%
Diametric Capital, LP15,450$107.5K0.07%
Police & Firemen's Retirement System of New Jersey14,474$100.7K0.00%
Corton Capital Inc.14,416$100.3K0.06%
Foundations Investment Advisors, LLC13,100$91.2K0.00%
SLT Holdings LLC13,100$91.2K0.09%
Ameriprise Financial Inc12,605$87.7K0.00%
Avantax Advisory Services, Inc.11,179$77.8K0.00%
Bank of Montreal10,667$74.2K0.00%
BNP Paribas Arbitrage, SA10,631$74.0K0.00%
KLP Kapitalforvaltning AS10,400$72.4K0.00%
Simplex Trading, LLC10,228$71.0K0.00%
Sharpepoint LLC10,165$70.7K0.06%
Virtus ETF Advisers LLC10,127$70.5K0.03%
King Wealth10,000$70.0K0.01%
PEAK6 LLC8,095$56.3K0.00%
Militia Capital Partners, LP7,400$51.5K0.02%
Diadema Partners LP4,710$32.8K0.04%
EMC Capital Management2,575$18.0K0.01%
Mirae Asset Global Investments Co., Ltd.2,444$16.7K0.00%
GF Fund Management Co. Ltd.1,540$10.7K0.00%
Spire Wealth Management1,040$7.24K0.00%
R Squared Ltd450$3.13K0.00%
Daiwa Securities Group Inc.242$2.00K0.00%
Nisa Investment Advisors, LLC204$1.42K0.00%
SBI Securities Co., Ltd.196$1.36K0.00%
Kohmann Bosshard Financial Services, LLC66$4590.00%
EverSource Wealth Advisors, LLC13$900.00%
Ameriflex Group, Inc.13$880.00%
MAI Capital Management10$700.00%

Sold out (19)

Institutions that held Definium Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Definium Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding DFTX in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Raymond James Financial Services Advisors, Inc.12,789$72.8K
PEAK6 Investments LLC6,223$35.4K